Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida

BACKGROUND: The management of Candida infections faces many problems, such as a limited number of antifungal drugs, toxicity, resistance of Candida to commonly antifungal drugs, relapse of Candida infections, and the high cost of antifungal drugs. Though azole antifungal agents and derivatives conti...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Complement Altern Med
Auteurs principaux: Mandras, Narcisa, Nostro, Antonia, Roana, Janira, Scalas, Daniela, Banche, Giuliana, Ghisetti, Valeria, Del Re, Simonetta, Fucale, Giacomo, Cuffini, Anna Maria, Tullio, Vivian
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2016
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5006570/
https://ncbi.nlm.nih.gov/pubmed/27576581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-016-1316-5
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires